Rex L Jamison

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial
    Rex L Jamison
    Veterans Affairs Palo Alto Health Care Systems and Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94304, USA
    JAMA 298:1163-70. 2007
  2. ncbi Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study
    Rex L Jamison
    Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA
    Am J Kidney Dis 53:779-89. 2009
  3. ncbi Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study
    Rex L Jamison
    Division of Nephrology, Stanford University School of Medicine, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA
    Clin Trials 1:451-60. 2004

Detail Information

Publications3

  1. ncbi Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial
    Rex L Jamison
    Veterans Affairs Palo Alto Health Care Systems and Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94304, USA
    JAMA 298:1163-70. 2007
    ..Folic acid and B vitamins decrease homocysteine levels in this population but whether they lower mortality is unknown...
  2. ncbi Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study
    Rex L Jamison
    Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA
    Am J Kidney Dis 53:779-89. 2009
    ..Abnormalities in the gene regulating methylenetetrahydrofolate reductase (MTHFR) are associated with increased homocysteine levels and increased mortality in normal and chronic kidney disease (CKD) populations...
  3. ncbi Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study
    Rex L Jamison
    Division of Nephrology, Stanford University School of Medicine, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, USA
    Clin Trials 1:451-60. 2004
    ..Data will be stored and analyzed at a coordinating center. The study design has the power to detect a reduction in all cause mortality rate of 17%. Issues related to the unique features of the design of this study are discussed...